Pharmaceutical formulations comprising 9-cis-retinyl esters in a lipid vehicle
US10130606B2 · kind B2 · utility
1Cited by
17References
23Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Sep 23, 2016 |
| Grant date | Nov 20, 2018 |
| Priority date | — |
| Expiry date | Sep 23, 2036 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Pharmaceutical formulations comprising 9-cis-retinyl esters in a lipid vehicle are described as retinoid replacement therapies for treating retinal degenerations in humans.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.